Abstract

Worldwide, there is no single strategy for optimal management of patients with ASCUS (atypical squamous cells of undetermined significance) cytology reports. The objective of this study was to determine the kind of clinical management conducted among women with a first ASCUS Pap smear report. Prospective single cohort study at a cervical pathology unit in Santiago, Chile. This was an epidemiological, descriptive, observational and quantitative follow-up study on a cohort of women with ASCUS cytological reports. In the screening phase, 92,001 cervical cytological smears were collected in primary healthcare clinics. In the diagnostic phase, all women with a first ASCUS report were selected (n = 446). These women were asked to undergo the Pap test again and it was found that 301 women had normal results, 62 women had abnormal results and 83 did not repeat the test. In the diagnostic confirmation phase, the 62 women with abnormal results underwent colposcopy and, from these results, 58 of them underwent a biopsy. The results from the biopsies showed that 16 women had negative histological reports, 13 had CIN 1 and 29 had CIN 2+. In the treatment phase, the 42 women with lesions underwent a variety of treatments, according to the type of lesion. In the post-treatment phase, cytological and colposcopic monitoring was instituted. The clinical management consisted of traditional management of screening, diagnosis, diagnostic confirmation, treatment and post-treatment monitoring.

Highlights

  • Atypical squamous cells of undetermined significance (ASCUS) are the most prevalent abnormality in cervical cytological evaluations

  • In Chile, the Ministry of Health (Minsal) has developed clinical guidelines that contain two clinical decision diagrams called the “algorithm for conveying the first atypical Pap test according to Bethesda 2001 classification, to a specialist or cervical pathology unit (CPU)” and the “algorithm for diagnostic confirmation”

  • These diagrams contain the steps for diagnostic confirmation and treatment of cervical atypia and are based on the first consensus guidelines for management of these cervical atypia, published by Wright et al.,[7] which were based on the multicenter study titled Atypical Squamous Cells of Undetermined Significance/Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS).[8]

Read more

Summary

Introduction

Atypical squamous cells of undetermined significance (ASCUS) are the most prevalent abnormality in cervical cytological evaluations. In Chile, the Ministry of Health (Minsal) has developed clinical guidelines that contain two clinical decision diagrams called the “algorithm for conveying the first atypical Pap test according to Bethesda 2001 classification, to a specialist or cervical pathology unit (CPU)” and the “algorithm for diagnostic confirmation”.5,6. These diagrams contain the steps for diagnostic confirmation and treatment of cervical atypia and are based on the first consensus guidelines for management of these cervical atypia, published by Wright et al.,[7] which were based on the multicenter study titled Atypical Squamous Cells of Undetermined Significance/Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS).[8]. This challenge is consistent with the objectives set by Minsal, which has the goal of generating clinical algorithms supported by national scientific evidence.[14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call